Seven dead as meningitis outbreak grows
ATLANTA (CNN) — The death toll from an outbreak of fungal meningitis linked to contaminated steroid injections has risen to seven, the Centers for Disease Control and Prevention said Saturday.
The total number of cases has also grown to 64 people in nine states, the CDC said. That is 17 more cases and two more states than the day before.
Patients contracted the deadly meningitis after being injected in their spine with a preservative-free steroid called methylprednisolone acetate that was contaminated by a fungus. The steroid is used to treat pain and inflammation.
Health officials say 76 medical facilities in 23 states received the contaminated products, which were manufactured by New England Compounding Center in Framingham, Massachusetts.
NECC voluntarily recalled three lots of the injectible steroid last week. As a precaution, the Food and Drug Administration is asking doctors, clinics, and consumers to stop using any products made by NECC.
The FDA is investigating the scope and cause of the outbreak.
The CDC raised the death toll Saturday after two people died in Michigan. Other deaths have been reported in Maryland, Tennessee, and Virginia.
Tennessee is reporting the most number of overall cases — 29 — which includes three deaths, according to the CDC.
Confirmed cases have also been found in Florida, Indiana, Minnesota, North Carolina and Ohio.
The other states that received the contaminated products from NECC are California, Connecticut, Georgia, Idaho, Illinois, New Hampshire, New Jersey, Nevada, New York, Pennsylvania, Rhode Island, South Carolina, Texas and West Virginia.
Nearly 10% of drugs administered in the United States come from compound pharmacies, according to a 2003 Government Accountability Office report.
Drugs manufactured by compound pharmacies do not have to go through FDA-mandated pre-market approval. Instead, oversight and licensing of these pharmacies comes from state health pharmacy boards.
Compound pharmacists create customized medication solutions for patients for whom manufactured pharmaceuticals won’t work, according to the International Academy of Compounding Pharmacists.
Meningitis is an inflammation of the protective membranes covering the brain and spinal cord. It is usually caused by an infection, frequently with bacteria or a virus, but it can also be caused by less common pathogens like fungi, according to the CDC.
Fungal meningitis is very rare and, unlike viral and bacterial meningitis, it is not contagious.
Symptoms of fungal meningitis are similar to symptoms from other forms of meningitis, but they often appear more gradually and can be very mild at first, the CDC says.
Dr. William Schaffner, chairman of the Department of Preventive Medicine at Vanderbilt University Medical Center, told CNN that fungal infections are not usually mild. He said when a fungus invades small blood vessels, it can cause them to clot or bleed, which can lead to symptoms of small strokes.
In addition to typical meningitis symptoms like headache, fever, nausea, and stiffness of the neck, people with fungal meningitis may also experience confusion, dizziness, and discomfort from bright lights. Patients might just have one or two of these symptoms, the CDC says.
A list of the 76 affected medical facilities is on the CDC’s website atwww.cdc.gov/hai/outbreaks/meningitis-facilities-map.html.
Health officials say any patients who received an injection at one of the facilities beginning July 1 and who began showing symptoms between one and three weeks after injection should see their doctor right away.
The earlier a patient gets treatment, the more likely he or she will survive.
Patients are treated with anti-fungal medication, which is given intravenously so patients have to be admitted to the hospital — at least in the beginning, the CDC said. Patients may need to be treated for months.
The FDA is urging anyone who has experienced problems following an injection with the NECC product, to report it to MedWatch, the FDA’s voluntary reporting program, by phone at 1-800-FDA-1088 or online at www.fda.gov/medwatch/report.htm.